ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.612,22
-1,13%
S&P 500
6.051,09
0,00%
US Dollar vs BRL
6,0424
0,00%
Bitcoin
101.684,83
0,23%
Brent Oil
74,135
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Photocure Asa (0IMT)

  7. Photocure Asa (0IMT) Notícias

0IMT

Photocure Asa (0IMT)

Photocure Asa
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:0IMT
DataHoraFonteTítuloCódigoCompanhia
09/08/202303:30PR Newswire (US)Photocure ASA: Results for the second quarter and first half of 2023LSE:0IMTPhotocure Asa
06/07/202305:57PR Newswire (US)Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in ChinaLSE:0IMTPhotocure Asa
10/05/202303:18PR Newswire (US)Photocure ASA: Results for the first quarter of 2023LSE:0IMTPhotocure Asa
04/05/202308:48PR Newswire (US)Photocure ASA - Correction: Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202313:58PR Newswire (US)Photocure ASA - Annual general meeting heldLSE:0IMTPhotocure Asa
03/05/202306:53PR Newswire (US)Photocure ASA: Invitation to presentation of first quarter 2023 financial resultsLSE:0IMTPhotocure Asa
02/05/202312:35PR Newswire (US)Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light CystoscopyLSE:0IMTPhotocure Asa
12/04/202311:14PR Newswire (US)Photocure ASA: Annual Report 2022LSE:0IMTPhotocure Asa
12/04/202311:14PR Newswire (US)Photocure ASA - Notice of the Annual General Meeting 3 May 2023LSE:0IMTPhotocure Asa
14/03/202304:53PR Newswire (US)Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancerLSE:0IMTPhotocure Asa
23/02/202304:29PR Newswire (US)Photocure ASA: Results for the fourth quarter of 2022LSE:0IMTPhotocure Asa
20/02/202303:43PR Newswire (US)Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLCLSE:0IMTPhotocure Asa
03/01/202303:47PR Newswire (US)New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursementLSE:0IMTPhotocure Asa
05/12/202204:08PR Newswire (US)New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO MeetingLSE:0IMTPhotocure Asa
07/11/202204:11PR Newswire (US)Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance settingLSE:0IMTPhotocure Asa
02/11/202204:38PR Newswire (US)Photocure ASA: Results for the third quarter of 2022LSE:0IMTPhotocure Asa
04/10/202202:52PR Newswire (US)Data presented at the International Bladder Cancer Network (IBCN) meeting demonstrate a reduction in the risk of recurrence with the use of BLCLSE:0IMTPhotocure Asa
28/09/202203:13PR Newswire (US)Photocure Announces the Commercial Availability of Karl Storz's New Blue Light System in the U.S.LSE:0IMTPhotocure Asa
20/09/202202:54PR Newswire (US)New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesiaLSE:0IMTPhotocure Asa
08/09/202202:44PR Newswire (US)Bladder Cancer technology: New KARL STORZ Blue Light Cystoscopy system featured during E-Masterclass in UrologyLSE:0IMTPhotocure Asa
01/09/202203:20PR Newswire (US)Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical DevelopmentLSE:0IMTPhotocure Asa
10/08/202203:18PR Newswire (US)Photocure ASA: Results for the second quarter of 2022LSE:0IMTPhotocure Asa
09/08/202205:47PR Newswire (US)Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical TrialLSE:0IMTPhotocure Asa
04/08/202210:15PR Newswire (US)Photocure ASA: Invitation to presentation of second quarter and first half year 2022 financial resultsLSE:0IMTPhotocure Asa
05/07/202202:41PR Newswire (US)Photocure Collaborations at EAU Support the Latest Advancements in Bladder Cancer TechnologyLSE:0IMTPhotocure Asa
13/06/202202:50PR Newswire (US)Positive Data from the Danish National Patient Registry presented at the 2022 Nordic Urologisk Forening (NUF) Congress in HelsinkiLSE:0IMTPhotocure Asa
18/05/202202:46PR Newswire (US)Blue Light Cystoscopy continues to make news at AUA 2022LSE:0IMTPhotocure Asa
11/05/202203:18PR Newswire (US)Photocure ASA: Results for the first quarter of 2022LSE:0IMTPhotocure Asa
29/03/202212:14PR Newswire (US)Photocure to Participate in Two Investor Conferences in April: DNB Small & Medium Enterprises and Needham HealthcareLSE:0IMTPhotocure Asa
11/03/202204:59PR Newswire (US)Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in ChinaLSE:0IMTPhotocure Asa
 Apresentando as notícias mais relevantes sobre:LSE:0IMT

Seu Histórico Recente

BOV
BRKM5
BRASKEM PNA
BOV
TELB4
TELEBRAS PN
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados